Galaxy Surfactants Q1FY27 Investor Presentation: EBITDA Surges 87% to ₹252 Cr
Galaxy Surfactants reported Q1FY27 results with EBITDA surging 87% YoY to ₹252 Cr and EBITDA/MT improving to ₹35,458. Total revenue grew 39.4% to ₹1,781.9 Cr. India returned to double-digit volume growth. Management cited disciplined pricing and operational excellence for the strong performance.
The significant increase in EBITDA and revenue, coupled with a return to double-digit growth in the crucial Indian market, suggests a material positive impact on the company's financial health and market position.
The company reported strong year-on-year growth in key financial metrics like EBITDA and revenue, indicating a positive financial performance. The commentary from the Managing Director also reflects confidence and strategic success.
Galaxy Surfactants Limited has released its investor presentation for the Unaudited Financial Results for the quarter ended June 30, 2026 (Q1FY27). The company reported a significant EBITDA growth of 87% year-on-year, reaching ₹252 Crore from ₹135 Crore in Q1FY26. EBITDA per metric ton also improved to ₹35,458/MT.
This strong performance was driven by disciplined pricing, a favorable product mix within the Specialty Care segment, operational excellence, improved operating leverage, and robust risk management, despite volatile raw material prices. Consolidated volume growth was in the mid-single digits, with balanced contributions from both Performance Surfactants and Specialty Care segments.
India demonstrated a notable return to double-digit volume growth after nearly two years, significantly outperforming market growth. The AMET region experienced a low-single-digit year-on-year decline due to geopolitical disruptions but showed encouraging high-teen sequential growth. The ROW region posted mid-single-digit growth, led by APAC and improving momentum in the Americas.
Raw material markets remained volatile, with elevated fatty alcohol prices and higher petrochemical feedstock costs due to increased crude oil prices. The Managing Director, Mr. K. Natarajan, expressed satisfaction with the company's ability to translate strategic foundations into tangible outcomes and leverage a diversified portfolio to emerge stronger in a challenging environment. He highlighted the team's efforts and collaboration in ensuring agility and flawless execution amidst external disruptions. The company remains confident in delivering sustainable long-term growth through disciplined execution and a customer-centric approach.
What to do with a filing like this
Galaxy Surfactants Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Galaxy Surfactants Limited. Read the original for the full detail.